ZFP64 and gastric cancer: Furthermore, three genes that we found to be amplified in serum-treated HEK293T cells (i.e., AURKA, RAE1, and ZFP64) are known to increase the resistance of pancreatic, colorectal, and gastric cancer cells to paclitaxel [54,55,56].